Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Operating Leases: 2022-2024

Historic Operating Leases for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $1.7 million.

  • Orchestra BioMed Holdings' Operating Leases fell 21.34% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 21.34%. This contributed to the annual value of $1.7 million for FY2024, which is 62.52% up from last year.
  • As of FY2024, Orchestra BioMed Holdings' Operating Leases stood at $1.7 million, which was up 62.52% from $1.0 million recorded in FY2023.
  • Over the past 5 years, Orchestra BioMed Holdings' Operating Leases peaked at $1.7 million during FY2024, and registered a low of $1.0 million during FY2023.
  • Moreover, its 3-year median value for Operating Leases was $1.7 million (2022), whereas its average is $1.5 million.
  • As far as peak fluctuations go, Orchestra BioMed Holdings' Operating Leases slumped by 38.32% in 2023, and later surged by 62.52% in 2024.
  • Yearly analysis of 3 years shows Orchestra BioMed Holdings' Operating Leases stood at $1.7 million in 2022, then crashed by 38.32% to $1.0 million in 2023, then spiked by 62.52% to $1.7 million in 2024.